03.14.18
Varubi® IV Distribution Suspension
Tesaro elects to suspend distribution of Varubi® (rolapitant) IV. Beginning March 14, 2018, ASD Healthcare will no longer accept orders for Varubi IV.
Read more >
03.14.18  URGENT: Bracco issues voluntary recall
Bracco is conducting a voluntary recall for one lot of E-Z-PASTE® Barium Sulfate Esophageal Cream (60% w/w) due to an out of specification result for a preservative assay, methylparaben, during stability testing on one lot of E-Z-PASTE®.
Read more >
02.28.18  URGENT: AstraZeneca voluntary recalls 8 lots of Lynparza
AstraZeneca is conducting a voluntary recall for 8 lots of LYNPARZA® (olaparib) capsules, 50 mg (112 count per bottle) due to elevated levels of quality attribute “Form L” (polymorph). The affected lots were distributed between Nov. 22, 2016, through Dec. 20, 2017.
Read more >
02.23.18  Urgent: Hospira issues a voluntary recall for Labetalol Hydrochloride Injection, USP and Labetalol Hydrochloride Injection, USP, Novaplus®
Hospira issues a voluntary recall for Labetalol Hydrochloride Injection, USP and Labetalol Hydrochloride Injection, USP, Novaplus®.
Read more >
01.26.18  URGENT: Kedrion Biopharma issues important correction of carton label information on MICRhoGAM® Ultra-Filtered PLUS {Rho(D) Immune Globulin (Human)} 5 Pack Carton
Kedrion Biopharma recently became aware of a typographical error in the carton labeling for the 5-Pack cartons of MICRhoGAM Ultra-Filtered PLUS {Rho(D) Immune Globulin (Human)}.
Read more >
11.22.17  CSL Behring issues a product information advisory for Albumin Human 25% Solution
CSL Behring L.L.C, is issuing a product information advisory involving Albumin Human 25% Solution AlbuRx® 25, 50 mL and 100 mL expiring on or before May 30, 2020. 
Read more >
Displaying results 1-5 (of 26)
 |<  < 1 - 2 - 3 - 4 - 5 - 6  >  >|